Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential?

Long-acting cabotegravir (CAB-LA) provides an exciting new option for pre-exposure prophylaxis (PrEP) in multiple populations. In this Perspective, we consider the unique pharmacokinetics of CAB-LA and the potential impact on the prescribing of CAB-LA, specifically in cis-women of reproductive poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahloff, Eric G, Hamons, Nikki, Baumgartner, Kevin, Duggan, Joan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274437/
https://www.ncbi.nlm.nih.gov/pubmed/35836749
http://dx.doi.org/10.1093/ofid/ofac230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274437/
https://www.ncbi.nlm.nih.gov/pubmed/35836749
http://dx.doi.org/10.1093/ofid/ofac230

Ejemplares similares